Cooper Companies offers a rare combination of recurring medical-device revenue, durable contact lens share gains, improving margins, and litigation-discounted valuation, creating an asymmetric five-year risk-reward profile.
Overview
Cooper Companies is a diversified global medical-device leader focused on ophthalmic care and reproductive health. Its CooperVision segment sells recurring-use contact lenses through practitioners and optical retailers, while CooperSurgical provides fertility, contraception, and surgical products to clinics and physicians. The business is geographically diversified across the Americas, EMEA, and APAC, with core strengths in premium daily silicone hydrogel lenses, toric and multifocal designs, MiSight pediatric myopia management, PARAGARD, IVF media, ZyMot, and Witness lab tracking. Customers value Cooper’s clinical performance, comfort, reliability, and integrated fertility solutions.